---
id: bacterial-pneumonia-bronchopneumonia_141
category: radiology
tags: [bacterial-pneumonia, bronchopneumonia, patchy-infiltrates, chest-radiology, CT]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Bacterial Pneumonia - Bronchopneumonia Pattern

**Q:** What are the characteristic CT findings of bronchopneumonia, and how does it differ from lobar pneumonia?

**A:**

## DEFINITION

**Bronchopneumonia:** **"Patchy, multifocal consolidation centered around bronchi with bilateral involvement"**

**Pathophysiology:** Infection spreads bronchogenically → inflammation around small airways → patchy peribronchial consolidation

**Key Point:** **Bronchopneumonia = patchy, multifocal, bilateral** (vs lobar = homogeneous, single lobe)

---

## CT FINDINGS

**Hallmark: Patchy Multifocal Consolidation (Peribronchial)**

### **Mnemonic: "PATCHY BRONCHI"**

**P**atchy consolidation (multifocal)
**A**round bronchi (peribronchial distribution)
**T**ree-in-bud nodules (endobronchial spread)
**C**entrilobular nodules (bronchocentric)
**H**eterogeneous (variable density)
**Y**ounger and older extremes (children, elderly)

**B**ilateral (usually both lungs)
**R**andom distribution (no lobar pattern)
**O**ften basilar predominance (lower lobes)
**N**ecrotizing (if S. aureus, Klebsiella)
**C**avitation may occur (necrotizing organisms)
**H**azy borders (ill-defined margins)
**I**ll-defined nodules and consolidation

**Key Point:** **Patchy bilateral infiltrates = bronchopneumonia** (vs lobar = consolidated single lobe)

---

## DISTRIBUTION CHARACTERISTICS

**Location:**
- **Bilateral** (>80% of cases)
- **Lower lobes > upper lobes** (basilar predominance)
- **Patchy, multifocal** (not respecting segmental boundaries)
- **Peribronchial** (centered around airways)

**Pattern:**
- **Centrilobular nodules** (2-10mm, centered on small airways)
- **Tree-in-bud pattern** (if endobronchial spread)
- **Ground-glass opacities** (early or peripheral)
- **Consolidation patches** (variable size)

**Key Point:** **Centrilobular nodules + tree-in-bud = bronchogenic spread**

---

## BRONCHOPNEUMONIA vs LOBAR PNEUMONIA

| **Feature** | **Bronchopneumonia** | **Lobar Pneumonia** |
|-------------|----------------------|---------------------|
| **Distribution** | **Patchy, multifocal** | **Lobar/segmental** |
| **Laterality** | **Bilateral** (usually) | **Unilateral** (single lobe) |
| **Borders** | **Ill-defined, hazy** | **Sharp, respects fissures** |
| **Air bronchograms** | **Less prominent** | **Prominent** |
| **Consolidation** | **Heterogeneous patches** | **Homogeneous, dense** |
| **Organisms** | **S. aureus, H. flu, viral** | ***S. pneumoniae*** |
| **Age group** | **Children, elderly** | **Adults** |
| **Clinical** | **Subacute, less severe** | **Acute, severe** |
| **Pattern** | **Peribronchial** | **Alveolar filling** |

**Key Point:** **Bronchopneumonia = bilateral patchy** | **Lobar = unilateral dense consolidation**

---

## ORGANISMS CAUSING BRONCHOPNEUMONIA

**Mnemonic: "STAPH-VIRUS"**

**S**taph aureus (most common - post-influenza, IVDU)
**T**ypical and atypical mix
**A**naerobes (aspiration bronchopneumonia)
**P**seudomonas (nosocomial, bronchiectasis, CF)
**H**. influenzae (COPD, elderly)

**V**iral (influenza, RSV, COVID-19 early)
**I**nfluenza (predisposes to bacterial superinfection)
**R**espiratory viruses (RSV, parainfluenza, adenovirus)
**U**sually in extremes of age (children, elderly)
**S**trep pneumoniae (can cause bronchopneumonia pattern)

**Key Point:** **S. aureus = most common cause of bacterial bronchopneumonia** (post-influenza, necrotizing)

---

## NECROTIZING BRONCHOPNEUMONIA

**High-Risk Organisms:**
- ***Staphylococcus aureus*** (most common - post-influenza, MRSA, PVL toxin)
- ***Klebsiella pneumoniae*** (alcoholics, "currant jelly" sputum)
- ***Streptococcus pyogenes*** (Group A Strep - rare, fulminant)
- ***Pseudomonas aeruginosa*** (nosocomial, immunocompromised)

**CT Features:**
- **Cavitation** (multiple, bilateral)
- **Pneumatoceles** (thin-walled air-filled cysts)
- **Ground-glass halo** (hemorrhage from vascular invasion)
- **Rapid progression** (hours to days)

**Key Point:** **Necrotizing pneumonia = S. aureus post-influenza** (cavitation, pneumatoceles, fulminant)

---

## POST-INFLUENZA BACTERIAL PNEUMONIA

**Timing:** **1-4 weeks after influenza infection**

**Mechanism:**
1. **Influenza damages airway epithelium**
2. **Impaired mucociliary clearance**
3. **Bacterial superinfection** (secondary invasion)

**Organisms:**
- ***S. aureus*** (MSSA, MRSA, CA-MRSA with PVL toxin) - **most common, most severe**
- ***S. pneumoniae***
- ***H. influenzae***
- ***Group A Streptococcus*** (rare, fulminant)

**Clinical Features:**
- **"Biphasic illness"** (influenza symptoms → brief improvement → sudden worsening)
- **High fever, productive cough**
- **Hemoptysis** (necrotizing)
- **Rapid deterioration** (shock, ARDS)

**Imaging:**
- **Bilateral patchy consolidation** (bronchopneumonia pattern)
- **Cavitation, pneumatoceles** (if S. aureus)
- **Rapid progression**

**Key Point:** **Post-influenza pneumonia = S. aureus bronchopneumonia** (necrotizing, high mortality)

---

## ASPIRATION BRONCHOPNEUMONIA

**Risk Factors:**
- **Aspiration** (altered mental status, EtOH, seizure, stroke, dysphagia)
- **Poor dentition** (anaerobic source)
- **GERD, achalasia**

**Location:** **Dependent segments**
- **Supine:** Posterior segments (RUL, RLL superior segments)
- **Upright:** Basilar segments (RLL, LLL)

**Organisms:**
- **Anaerobes** (Peptostreptococcus, Fusobacterium, Prevotella) - foul-smelling
- **Mixed aerobic-anaerobic** (polymicrobial)
- ***S. aureus***, gram-negatives (if nosocomial)

**Imaging:**
- **Patchy consolidation** (dependent segments)
- **May progress to lung abscess** (thick-walled cavity, air-fluid level)

**Key Point:** **Aspiration bronchopneumonia → lung abscess** (if anaerobic, necrotizing)

---

## CLINICAL PRESENTATION

**Bronchopneumonia Features:**
- **Subacute onset** (days to 1 week)
- **Low-grade fever** (vs high fever in lobar)
- **Productive cough** (variable sputum)
- **Dyspnea** (gradual worsening)
- **Diffuse crackles** on exam (bilateral)

**Severe Features (Necrotizing):**
- **Hemoptysis** (S. aureus, Klebsiella)
- **Rapid deterioration** (ARDS, shock)
- **High mortality** (especially CA-MRSA with PVL)

**Key Point:** **Bronchopneumonia = subacute, less severe** (unless necrotizing)

---

## COMPLICATIONS

**Mnemonic: "CAVITIES"**

**C**avitation (necrotizing organisms)
**A**RDS (severe bilateral disease)
**V**ascular invasion (septic emboli)
**I**nfluenza predisposition (superinfection)
**T**oxic shock syndrome (S. aureus PVL toxin)
**I**ntubation often required (respiratory failure)
**E**mpyema (if rupture into pleura)
**S**eptic shock (high mortality)

**Key Point:** **Necrotizing bronchopneumonia = ARDS, shock** (high mortality)

---

## TREATMENT

**Community-Acquired Bronchopneumonia (Non-Necrotizing):**

**Outpatient:**
- **Amoxicillin-clavulanate** 875mg PO BID x 5-7 days OR
- **Doxycycline** 100mg PO BID x 5-7 days OR
- **Levofloxacin** 750mg PO daily x 5 days

**Inpatient:**
- **Ceftriaxone** 1-2g IV daily + **azithromycin** 500mg IV/PO daily OR
- **Ampicillin-sulbactam** 3g IV q6h (if aspiration concern)

---

**Post-Influenza Bacterial Pneumonia (S. aureus Coverage):**

**Empiric (covers MRSA):**
- **Vancomycin** 15-20 mg/kg IV q8-12h (target trough 15-20) + **Ceftriaxone** 2g IV daily OR
- **Linezolid** 600mg IV/PO q12h + **Ceftriaxone** 2g IV daily

**If CA-MRSA with PVL Toxin Suspected:**
- **Vancomycin** + **Ceftriaxone** + **Clindamycin** 600-900mg IV q8h (toxin suppression)

**Duration:** 7-14 days (longer if necrotizing, cavitation)

**Key Point:** **Post-influenza pneumonia = cover MRSA** (vancomycin or linezolid)

---

## IMAGING FOLLOW-UP

**Bronchopneumonia Resolution:**
- **Clinical improvement:** 3-5 days (slower than lobar)
- **CXR improvement:** 1-2 weeks
- **Complete resolution:** 4-8 weeks

**Delayed Resolution:**
- **Necrotizing organisms** (S. aureus, Klebsiella)
- **Immunocompromised**
- **Underlying lung disease** (COPD, bronchiectasis)
- **Complications** (abscess, empyema)

**Key Point:** **Follow-up CXR at 6-8 weeks** (ensure resolution, exclude underlying lesion)

---

**Clinical Pearls:**
- **Bronchopneumonia = patchy, bilateral, peribronchial** (vs lobar = homogeneous, single lobe)
- **Centrilobular nodules + tree-in-bud = bronchogenic spread**
- **S. aureus = most common cause** (especially post-influenza)
- **Post-influenza pneumonia = biphasic illness** (influenza → improvement → sudden worsening)
- **Necrotizing bronchopneumonia = cavitation, pneumatoceles** (S. aureus, Klebsiella)
- **CA-MRSA with PVL toxin = fulminant, high mortality** (add clindamycin for toxin suppression)
- **Aspiration bronchopneumonia → lung abscess** (dependent segments, anaerobes)
- **Bilateral patchy infiltrates in extremes of age** (children, elderly)
- **Treatment: Cover MRSA if post-influenza** (vancomycin + ceftriaxone)
- **Resolution slower than lobar** (4-8 weeks for complete CXR clearing)

**Media:**

**Image 1 - Bronchopneumonia Pattern:**

*CXR showing bilateral patchy infiltrates with ill-defined margins, predominately in the lower lobes. Note the multifocal nature and absence of lobar consolidation. Patient is a 72-year-old with COPD presenting with 5-day history of productive cough and dyspnea. Sputum culture grew *H. influenzae*.*

**Image 2 - Necrotizing Bronchopneumonia (S. aureus):**

*CT chest demonstrating bilateral patchy consolidation with multiple cavities and pneumatoceles. Patient is a 35-year-old who developed bacterial pneumonia 2 weeks post-influenza. Blood cultures grew MRSA with PVL toxin. Developed ARDS requiring mechanical ventilation.*

**Image 3 - Tree-in-Bud Pattern (Bronchopneumonia):**

*HRCT showing centrilobular nodules with tree-in-bud appearance indicating endobronchial spread. Bilateral patchy ground-glass opacities and consolidation. Patient with aspiration bronchopneumonia from anaerobic organisms (foul-smelling sputum, poor dentition).*

**Additional Resources:**
- **Radiopaedia.org:** Search "bronchopneumonia," "necrotizing pneumonia," "tree-in-bud pattern"
- **PMC6100641:** Imaging patterns of bacterial pneumonia
- **IDSA/ATS CAP Guidelines 2019:** Treatment algorithms

**Sources:** [Radiopaedia - Bronchopneumonia], [IDSA/ATS CAP Guidelines 2019], [Chest 2011 - Post-influenza bacterial pneumonia]
